• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4
1
1
1

COUNTRY

1

CATEGORIES

  • 36
  • 14
  • 7
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

9
9
59
65

PUBLISHED

0
13
49
65

PRODUCT TYPE

56
9

Search "Cubist Pharmaceuticals Inc.-Therapeutic Competitors" returned 65 results.

PRODUCT TITLE

Cubist Pharmaceuticals, Inc. (CBST) - Financial and Strategic SWOT Analysis Review

Cubist Pharmaceuticals, Inc. (CBST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Cubist Pharmaceuticals Incorporated

A textual analysis of the financial results for Cubist Pharmaceuticals Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements,...

December 2014

Achillion Pharmaceuticals, Inc. (ACHN) - Financial and Strategic SWOT Analysis Review

Achillion Pharmaceuticals, Inc. (ACHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

April 2014
FROM

United Therapeutics Corporation

A textual analysis of the financial results for United Therapeutics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

February 2015
FROM

Alnylam Pharmaceuticals, Inc. (ALNY) - Financial and Strategic SWOT Analysis Review

Alnylam Pharmaceuticals, Inc. (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

February 2015
FROM

Vertex Pharmaceuticals Inc

A textual analysis of the financial results for Vertex Pharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

February 2015
FROM
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review

Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review Summary Alnylam Pharmaceuticals, Inc., (Alnylam) is a biopharmaceutical company focusing on the discovery, development...

April 2012
FROM

Salix Pharmaceuticals, Ltd.

A textual analysis of the financial results for Salix Pharmaceuticals, Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

February 2015
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2015

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2015 Summary This, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2015’, provides an overview of the Hospital Acquired Pneumonia (HAP)’s...

January 2015
FROM

Complicated Intra-Abdominal Infections - Pipeline Review, H2 2014

Complicated Intra-Abdominal Infections - Pipeline Review, H2 2014 Summary This, ‘Complicated Intra-Abdominal Infections - Pipeline Review, H2 2014’, provides an overview of the Complicated Intra-Abdominal...

August 2014
FROM

Complicated Intra-Abdominal Infections - Pipeline Review, H1 2014

Complicated Intra-Abdominal Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Complicated Intra-Abdominal Infections - Pipeline Review, H1 2014’, provides an overview of the...

March 2014
FROM
Skin And Soft Tissue Infections - Pipeline Review, H2 2014 Skin And Soft Tissue Infections - Pipeline Review, H2 2014 - Product Thumbnail Image

Skin And Soft Tissue Infections - Pipeline Review, H2 2014

Skin And Soft Tissue Infections - Pipeline Review, H2 2014 Summary This, ‘Skin And Soft Tissue Infections - Pipeline Review, H2 2014’, provides an overview of the Skin And Soft Tissue Infections’s...

November 2014
FROM
Pyelonephritis - Pipeline Review, H2 2014 Pyelonephritis - Pipeline Review, H2 2014 - Product Thumbnail Image

Pyelonephritis - Pipeline Review, H2 2014

Pyelonephritis - Pipeline Review, H2 2014 Summary This, ‘Pyelonephritis - Pipeline Review, H2 2014’, provides an overview of the Pyelonephritis’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Pyelonephritis - Pipeline Review, H1 2014

Pyelonephritis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pyelonephritis - Pipeline Review, H1 2014’, provides an overview of the Pyelonephritis’s therapeutic pipeline. This report...

May 2014
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014’, provides an overview of the Ventilator...

February 2014
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2014’, provides an overview of the Hospital Acquired...

June 2014
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015 Summary This, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015’, provides an overview of the Ventilator Associated...

January 2015
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014 Summary This, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2014’, provides an overview of the Hospital Acquired Pneumonia (HAP)’s...

December 2014
FROM

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014

Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014 Summary This, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2014’, provides an overview of the Ventilator Associated...

July 2014
FROM

Gonorrhea - Pipeline Review, H2 2014

Gonorrhea - Pipeline Review, H2 2014 Summary This, ‘Gonorrhea - Pipeline Review, H2 2014’, provides an overview of the Gonorrhea’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM
Loading Indicator

Our Clients

Carrefour S.A. Dow Chemical Co Ltd. Motorola Solutions, Inc. Pfizer, Inc. Activision Publishing, Inc. 3M Company Estée Lauder Companies Inc.